Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isokinetic muscle function in COPD.

Charles Haccoun1, Argyrios A Smountas, William J Gibbons

  • 1Montreal Children's Hospital-McGill University Health Centre, Montreal, PQ, Canada.

Chest
|April 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026
Same author

Moving the goalposts from symptom control to preventing airway remodeling in preschool asthma.

Paediatric respiratory reviews·2026
Same author

Dupilumab in COPD: A Pooled Analysis of Emergency Department Visits, Hospital Admissions, and Systemic Corticosteroid Use.

American journal of respiratory and critical care medicine·2026
Same author

Reproducibility of the 6-Minute Walk Test on a 20-Metre Course in Community Dwelling Adults With Chronic Obstructive Pulmonary Disease.

Physiotherapy Canada. Physiotherapie Canada·2026
Same author

Poor Sleep Quality and Heightened Perceptual Responses to Exercise in Community Dwellers: Results from the CanCOLD Study.

Annals of the American Thoracic Society·2026
Same author

A GOLD Science Committee Perspective on Exacerbations and Cardiovascular Risk In COPD.

American journal of respiratory and critical care medicine·2026

A 20-second isokinetic test effectively predicts maximal exercise capacity in patients with chronic obstructive pulmonary disease (COPD), combining lung function (FEV1) and leg muscle function. This offers a practical alternative to longer tests for assessing exercise limitation in COPD.

Area of Science:

  • Pulmonary Medicine
  • Exercise Physiology
  • Rehabilitation Science

Background:

  • Exercise limitation in COPD is multifactorial, involving impaired lung function and reduced skeletal muscle function.
  • Previous prediction models for exercise capacity used FEV1 and a 30-second isokinetic sprint test.
  • The 30-second test may not be suitable for patients with advanced COPD.

Purpose of the Study:

  • To investigate the relationship between maximal exercise capacity (Wmax), FEV1, and shorter-duration isokinetic leg muscle function tests in COPD patients and healthy controls.
  • To determine if isokinetic work achieved at intervals less than 30 seconds can predict Wmax.
  • To assess the utility of a shorter isokinetic test for evaluating leg function in COPD.

Main Methods:

  • Twenty-seven COPD patients and 29 healthy controls underwent spirometry, progressive cycle ergometry, and 30-second isokinetic cycling.

Related Experiment Videos

  • Measurements included FEV1, Wmax, and isokinetic work at 10, 15, 20, 25, and 30 seconds (W10-W30).
  • Statistical analysis involved correlation and two-factor modeling to predict Wmax.
  • Main Results:

    • COPD patients had significantly lower FEV1 and Wmax compared to controls.
    • Wmax correlated significantly with FEV1 and all isokinetic work measures (W10-W30) in both groups.
    • Combining FEV1 and isokinetic work (e.g., W20) in a two-factor model yielded high coefficients of determination (r² ≈ 0.58 for COPD, ≈ 0.71 for controls).

    Conclusions:

    • Both ventilatory function and leg muscle function are critical determinants of exercise limitation in COPD.
    • A 20-second isokinetic test is a viable and practical tool for assessing leg muscle function and predicting exercise capacity in COPD patients.
    • This finding supports the use of shorter, well-tolerated tests in clinical practice for COPD management.